Ligand Pharmaceuticals Incorporated (LGND)

NGM – Real Time Price. Currency in USD

293.27

+4.52 (1.57%)

At close: Aug 12, 2026, 4:00 PM EDT

293.27

0.00 (0.00%)

After-hours: Aug 12, 2026, 4:04 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

268M

167M

131M

196M

Cost of goods sold

-47M

-46M

-43M

-77M

Gross Profit

221M

121M

88M

119M

Operating expenses (excl. COGS)

-174M

-98M

-78M

-106M

Operating Income

47M

23M

10M

13M

Non-operating income, total

112M

-21M

54M

23M

Pretax income

159M

64M

36M

Equity in earnings

Taxes

-35M

-7M

-10M

-41M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

124M

-4M

54M

-5M

Discontinued operations

-2M

-28M

Net income

124M

-4M

52M

-33M

Dilution adjustment

Preferred dividends

Ligand Pharmaceuticals Incorporated (LGND)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ligand Pharmaceuticals Incorporated (LGND)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Ligand Pharmaceuticals Incorporated (LGND)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ligand Pharmaceuticals Incorporated (LGND)

Income Statement (Annual)

Income Statement (Annual)